HALAUMA
ActiveSummary
HALAUMA has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €759,592 and a net result of €748,911. Equity is growing by ~4.8% per year across the filed fiscal years. Its solvency ranks better than 27% of 2372 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency56▼-16
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55,000 at 30 days acceptable
Liquidity tight (current ratio 1.29 against 1.99 in 2024; short-term debt: 51.6% and cash: 8.4% of total assets), and 69% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
31%
Return on assets
30.5%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-08-2026, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
26 d late
2024
14 d early
2023
56 d late
2022
30 d late
2021
31 d late
2020
9 d early
2019
18 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 15 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 30 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Equity
€759,592▼ 37.4%
2024 · €1.2m
Total assets
€2.5m▼ 4.1%
2024 · €2.6m
Net result
€748,911▲ 1.5%
2024 · €738,111
Working capital
€370,257▼ 56.1%
2024 · €843,970
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€715,880▲ 34.5%€747,940▲ 4.5%€843,800▲ 12.8%€1.0m▲ 19.1%€951,043▼ 5.4%
Net result€557,190above the sector's middle half▲ 39.8%€564,933above the sector's middle half▲ 1.4%€594,111above the sector's middle half▲ 5.2%€738,111above the sector's middle half▲ 24.2%€748,911above the sector's middle half▲ 1.5%
Equity€920,967within the sector's middle half▲ 22.7%€1.5mabove the sector's middle half▲ 61.3%€715,571within the sector's middle half▼ 51.8%€1.2mwithin the sector's middle half▲ 69.6%€759,592within the sector's middle half▼ 37.4%
Total assets€1.6mwithin the sector's middle half▲ 22.4%€1.9mwithin the sector's middle half▲ 16.8%€2.6mabove the sector's middle half▲ 34.1%€2.6mabove the sector's middle half▼ 0.2%€2.5mabove the sector's middle half▼ 4.1%
Debt€714,981▲ 22.1%€425,463▼ 40.5%€1.8m▲ 334%€1.3m▼ 27.3%€1.7m▲ 26.0%
Working capital€743,689within the sector's middle half▲ 36.9%€1.2mabove the sector's middle half▲ 62.9%€335,497within the sector's middle half▼ 72.3%€843,970within the sector's middle half▲ 152%€370,257within the sector's middle half▼ 56.1%
Solvency56.3%within the sector's middle half▲ 0.1pp77.7%within the sector's middle half▲ 21.4pp27.9%below the sector's middle half▼ 49.8pp47.5%within the sector's middle half▲ 19.5pp31.0%within the sector's middle half▼ 16.5pp
Current ratio2.40within the sector's middle half▲ 0.025.56within the sector's middle half▲ 3.161.25below the sector's middle half▼ 4.301.99within the sector's middle half▲ 0.741.29within the sector's middle half▼ 0.70
Return on assets (ROA)34.1%above the sector's middle half▲ 4.2pp29.6%above the sector's middle half▼ 4.5pp23.2%above the sector's middle half▼ 6.4pp28.9%above the sector's middle half▲ 5.7pp30.5%above the sector's middle half▲ 1.7pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 5% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.5m
Fixed assets
€817,479 ▼ 5.3%
Current assets
€1.6m ▼ 3.5%
Equity and liabilities €2.5m
Equity
€759,592 ▼ 37.4%
Debt
€1.7m ▲ 26.0%
Debt's share of the balance-sheet total rises from 52.5% to 69.0%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€996,612▼
2024 · €1.1m
Cash flow
€794,480▲
2024 · €785,684
Debt to equity
2.23▲
2024 · 1.11
ROE
98.6%▲
2024 · 60.8%
Interest coverage
14.94▲
2024 · 14.87
Debt ≤ 1 year
€1.3m▲
2024 · €850,661
Debt > 1 year
€373,283▼
2024 · €431,361
Income taxes
€247,814▲
2024 · €239,715
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 17,811 companies that looked in July 2024 the way this one looks now, 0.3% went bankrupt within 24 months and 97% are still going.
- Small
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.3%
went bankrupt
3.2%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 17,811 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | €12,000 | - | - | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €153,135 | €67,021 | €101,042 | €47,574 | €45,569 | ▼ 4.2% |
| Other operating charges640/8 | €5,424 | €4,581 | €4,906 | €5,838 | €6,702 | ▲ 14.8% |
| Gross operating margin9900 | €874,439 | €819,542 | €949,748 | €1.1m | €1.0m | ▼ 5.2% |
| Operating profit (loss)9901 | €715,880 | €747,940 | €843,800 | €1.0m | €951,043 | ▼ 5.4% |
| Financial income75/76B | €69,016 | €13,885 | €14,956 | €43,335 | €112,376 | ▲ 159% |
| Recurring financial income75 | €69,016 | €13,885 | €14,956 | €43,335 | €112,376 | ▲ 159% |
| Financial charges65/66B | €13,007 | €18,290 | €52,696 | €70,830 | €66,695 | ▼ 5.8% |
| Recurring financial charges65 | €13,007 | €18,290 | €52,696 | €70,830 | €66,695 | ▼ 5.8% |
| Profit (loss) for the period before taxes9903 | €771,888 | €743,535 | €806,060 | €977,825 | €996,725 | ▲ 1.9% |
| Income taxes67/77 | €214,698 | €178,602 | €211,949 | €239,715 | €247,814 | ▲ 3.4% |
| Profit (loss) for the period9904 | €557,190 | €564,933 | €594,111 | €738,111 | €748,911 | ▲ 1.5% |
| Transfer from tax-exempt reserves789 | €114,700 | - | €168,400 | - | - | - |
| Transfer to tax-exempt reserves689 | €168,400 | - | €210,500 | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €503,490 | €564,933 | €552,011 | €738,111 | €748,911 | ▲ 1.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.6m | €1.9m | €2.6m | €2.6m | €2.5m | ▼ 4.1% |
| Fixed assets21/28 | €359,637 | €434,006 | €890,762 | €863,047 | €817,479 | ▼ 5.3% |
| Tangible fixed assets22/27 | €359,637 | €434,006 | €890,762 | €863,047 | €817,479 | ▼ 5.3% |
| Plant, machinery and equipment23 | €24,790 | €23,900 | €17,399 | €10,898 | €4,690 | ▼ 57.0% |
| Furniture and vehicles24 | €71,711 | €55,799 | €39,888 | €23,976 | €8,065 | ▼ 66.4% |
| Other tangible fixed assets26 | €263,137 | €354,306 | €833,476 | €828,174 | €804,724 | ▼ 2.8% |
| Current assets29/58 | €1.3m | €1.5m | €1.7m | €1.7m | €1.6m | ▼ 3.5% |
| Amounts receivable within one year40/41 | €375,366 | €336,600 | €424,158 | €441,132 | €370,328 | ▼ 16.1% |
| Other amounts receivable41 | €375,366 | €336,600 | €424,158 | €441,132 | €370,328 | ▼ 16.1% |
| Current investments50/53 | €426,098 | €725,068 | €904,180 | €889,685 | €1.0m | ▲ 16.0% |
| Cash at bank and in hand54/58 | €396,561 | €378,674 | €312,131 | €334,132 | €206,109 | ▼ 38.3% |
| Deferred charges and accrued income490/1 | €78,285 | €37,015 | €32,397 | €29,682 | €26,649 | ▼ 10.2% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.6m | €1.9m | €2.6m | €2.6m | €2.5m | ▼ 4.1% |
| Equity10/15 | €920,967 | €1.5m | €715,571 | €1.2m | €759,592 | ▼ 37.4% |
| Contributions10/11 | €18,600 | €18,600 | €60 | €60 | €60 | = |
| Reserves13 | €773,260 | €773,260 | €713,500 | €1.2m | €610,500 | ▼ 49.7% |
| Non-distributable reserves130/1 | €1,860 | - | - | - | - | - |
| Reserves not available under the articles1311 | €1,860 | - | - | - | - | - |
| Tax-exempt reserves132 | €168,400 | €168,400 | €210,500 | €210,500 | €210,500 | = |
| Distributable reserves133 | €603,000 | €604,860 | €503,000 | €1.0m | €400,000 | ▼ 60.1% |
| Profit (loss) carried forward14 | €129,107 | €694,040 | €2,011 | €121 | €149,032 | ▲ 122,783% |
| Amounts payable17/49 | €714,981 | €425,463 | €1.8m | €1.3m | €1.7m | ▲ 26.0% |
| Amounts payable after more than one year17 | €170,258 | €149,265 | €488,145 | €431,361 | €373,283 | ▼ 13.5% |
| Financial debts170/4 | €170,258 | €149,265 | €488,145 | €431,361 | €373,283 | ▼ 13.5% |
| Amounts payable within one year42/48 | €532,622 | €265,918 | €1.3m | €850,661 | €1.3m | ▲ 48.7% |
| Current portion of amounts payable after more than one year42 | €20,912 | €20,993 | €55,494 | €56,784 | €58,077 | ▲ 2.3% |
| Trade debts44 | €8,916 | €78,768 | €12,125 | €50,244 | €1,316 | ▼ 97.4% |
| Suppliers440/4 | €8,916 | €78,768 | €12,125 | €50,244 | €1,316 | ▼ 97.4% |
| Taxes, remuneration and social security45 | €73,156 | €6,756 | €38,156 | €11,200 | €221,431 | ▲ 1,877% |
| Taxes450/3 | €73,156 | €6,756 | €38,156 | €11,200 | €221,431 | ▲ 1,877% |
| Other amounts payable47/48 | €429,639 | €159,401 | €1.2m | €732,433 | €983,849 | ▲ 34.3% |
| Accrued charges and deferred income492/3 | €12,101 | €10,281 | €22,543 | €61,976 | €54,860 | ▼ 11.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €557,190 | €564,933 | €594,111 | €738,111 | €748,911 | ▲ 1.5% |
| + Depreciation and write-downs630 | €153,135 | €67,021 | €101,042 | €47,574 | €45,569 | ▼ 4.2% |
| Operating cash flow (approximation) | €710,325 | €631,954 | €695,153 | €785,684 | €794,480 | ▲ 1.1% |
| Investment in fixed assets (approximation) | - | -€141,390 | -€557,798 | -€19,859 | €0 | ▲ 100% |
| Change in cash | - | -€17,887 | -€66,544 | €22,001 | -€128,023 | ▼ 682% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
26-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 26 days late
2025
31-12
Financial
Highest result since 2018net €748,911 ▲1.5%
Net result €748,911, the highest in the series.
17-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Equity above €1mEq €1.2m ▲69.6%
7 profitable years in a row build equity to €1.2m.
25-09
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 56 days late
2023
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 30 days late
2022
31-12
Financial
Liquidity doublescurrent ratio 5.56
Current ratio from 2.40 to 5.56; short-term debt falls from €532,622 to €265,918.
31-12
Financial
Equity above €1mEq €1.5m ▲61.3%
5 profitable years in a row build equity to €1.5m.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 31 days late
2021
22-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
13-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
18-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
19-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
17-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Roeselare · 1 establishment unit since 2014
Ground area
1,649 m²
Building footprint
241 m²
Volume, LiDAR
1 m³
Parcel 36013B0146/00K000, Flanders · tallest building 1.0 m. Linked by address, not a title deed.
1 establishment unit
HALAUMA
since 20142.238.334.386
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 36013B0146/00K000 | Flanders | 1,649 m² | 1 · 241 m² | 1.0 m |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
NANH
BE 0696.833.746
Charleroi · Eq €759,161
Dr. S. HUYBRECHTS - Dr. K. CASIER
BE 0480.448.720
Nazareth-De Pinte · Eq €758,836
DR. KOEN QUAEGEBEUR EN DR. MARIA VAN HELVOIRT
BE 0479.023.315
Houthulst · Eq €758,231
Prof. Dr. C. de Asmundis Cardiologie
BE 0735.832.694
Beersel · Eq €761,423
DOKTER VANWALLEGHEM JOHAN
BE 0881.941.222
Hasselt · Eq €761,832
Of 16,627 companies in sector 86220 we hold annual accounts for 7,986. 6,080 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded30-12-2014
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
82300Organisation of conventions and trade shows
85599Other education
E-invoicing
Reachable via Peppol
Peppol ID
0208:0507834491
Also
9925:BE0507834491
Registered
19-11-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.